TG THERAPEUTICS, INC. Payments of Financing Costs
TG THERAPEUTICS, INC. (TGTX) reported Payments of Financing Costs of $2.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2026-08-05
- TG THERAPEUTICS, INC. payments of financing costs for the quarter ending 2026-06-30 was $0.00.
- TG THERAPEUTICS, INC. payments of financing costs for the quarter ending 2026-03-31 was $2.60M.
- TG THERAPEUTICS, INC. payments of financing costs for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- TG THERAPEUTICS, INC. payments of financing costs for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- TG THERAPEUTICS, INC. payments of financing costs for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- TG THERAPEUTICS, INC. payments of financing costs for fiscal 2024 was $889.00K, a 611.20% increase from fiscal 2023.
- TG THERAPEUTICS, INC. payments of financing costs for fiscal 2023 was $125.00K.
- TG THERAPEUTICS, INC. payments of financing costs for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month | Payments of Financing Costs 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.60M 10-Q · filed 2026-08-05 | $2.60M derived: sum of 3 quarters · filed 2026-08-05 | $2.60M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $2.60M 10-Q · filed 2026-05-06 | $2.60M derived: sum of 2 quarters · filed 2026-05-06 | $2.60M derived: sum of 3 quarters · filed 2026-05-06 | $2.60M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $0.00 10-K · filed 2026-02-27 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2026-08-05 | $0.00 10-Q · filed 2025-11-05 | $31.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $31.00K derived: sum of 3 quarters · filed 2026-08-05 | $889.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-06 | $31.00K derived: sum of 2 quarters · filed 2026-05-06 | $889.00K derived: sum of 3 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $889.00K derived: sum of 2 quarters · filed 2026-02-27 | $889.00K 10-K · filed 2026-02-27 | ||
| 2024-09-30 | $858.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $858.00K 10-Q · filed 2025-11-05 | |||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-09 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 derived: sum of 3 quarters · filed 2026-02-27 | $125.00K 10-K · filed 2026-02-27 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $125.00K 10-Q · filed 2024-11-07 | $125.00K derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $125.00K 10-Q · filed 2024-08-09 | $125.00K derived: sum of 3 quarters · filed 2025-03-03 | ||
| 2023-03-31 | $125.00K 10-Q · filed 2024-05-06 | $125.00K derived: sum of 2 quarters · filed 2025-03-03 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 10-K · filed 2025-03-03 | |||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-06 | ||||
| 2021-12-31 | $1.02M 10-K · filed 2024-02-29 | ||||
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 | ||||
| 2019-12-31 | $315.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $315.00K derived: sum of 2 quarters · filed 2022-03-01 | $257.00K derived: sum of 3 quarters · filed 2022-03-01 | $795.00K 10-K · filed 2022-03-01 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$58.00K derived: sum of 2 quarters · filed 2020-11-09 | $480.00K 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | -$58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $480.00K 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | $538.00K 10-Q · filed 2020-05-11 | ||||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $0.00 derived: sum of 2 quarters · filed 2020-03-02 | $0.00 derived: sum of 3 quarters · filed 2020-03-02 | $0.00 10-K · filed 2020-03-02 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | $3.02K derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | $3.02K derived: sum of 3 quarters · filed 2019-03-01 | $9.01K derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-10 | $3.02K derived: sum of 2 quarters · filed 2019-03-01 | $9.01K derived: sum of 3 quarters · filed 2019-03-01 | $5.00K derived: sum of 4 quarters · filed 2019-03-01 | |
| 2016-12-31 | $3.02K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $9.01K derived: sum of 2 quarters · filed 2019-03-01 | $5.00K derived: sum of 3 quarters · filed 2019-03-01 | $13.00K 10-K · filed 2019-03-01 | $13.51K 10-K · filed 2017-03-16 |
| 2016-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.98K derived: sum of 2 quarters · filed 2017-11-09 | $9.98K 10-Q · filed 2017-11-09 | $45.75K derived: sum of 4 quarters · filed 2018-03-15 | |
| 2016-06-30 | -$4.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $3.99K 10-Q · filed 2017-08-09 | $39.76K derived: sum of 3 quarters · filed 2018-03-15 | $88.72K derived: sum of 4 quarters · filed 2018-03-15 | |
| 2016-03-31 | $8.00K 10-Q · filed 2017-05-10 | $43.77K derived: sum of 2 quarters · filed 2018-03-15 | $92.73K derived: sum of 3 quarters · filed 2018-03-15 | $92.73K derived: sum of 4 quarters · filed 2018-03-15 | |
| 2015-12-31 | $35.77K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $84.73K derived: sum of 2 quarters · filed 2018-03-15 | $84.73K derived: sum of 3 quarters · filed 2018-03-15 | $104.17K 10-K · filed 2018-03-15 | |
| 2015-09-30 | $48.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $48.97K derived: sum of 2 quarters · filed 2016-11-09 | $68.40K 10-Q · filed 2016-11-09 | $120.38K derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-06-30 | -$1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $19.44K 10-Q · filed 2016-08-09 | $71.42K derived: sum of 3 quarters · filed 2017-03-16 | $71.42K derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-03-31 | $19.44K 10-Q · filed 2016-05-10 | $71.42K derived: sum of 2 quarters · filed 2017-03-16 | $71.42K derived: sum of 3 quarters · filed 2017-03-16 | $71.42K derived: sum of 4 quarters · filed 2017-03-16 | |
| 2014-12-31 | $51.98K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $51.98K derived: sum of 2 quarters · filed 2017-03-16 | $51.98K derived: sum of 3 quarters · filed 2017-03-16 | $51.98K 10-K · filed 2017-03-16 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $0.00 10-Q · filed 2015-08-10 | |||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-11 | ||||
| 2013-12-31 | $85.12K 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |